Will doctors one day prescribe apps meant to drive behavior changes instead of drugs?

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.

Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.

If approved, Lucemyra (lofexidine) would be the first non-opioid drug approved to treat the symptoms of opioid withdrawal.